Sema4 Company is a patient-centered health intelligence company, which is a leader in diagnostic testing. The company initiated on the idea that more information, increased engagement, deeper analysis will improve the treatment, diagnosis, and prevention of disease.
On February 2018, Sema4 released supplemental newborn screening test ‘Sema4 Natalis’ that is designed to identify 193 childhood-onset disorders or diseases. Moreover, there is ... Read more
